PDCD1 and cancer: In this established paradigm, cancer cells express programmed death ligand 1 (PD-L1, the PD-1 ligand), which upon binding to T-cell-specific PD-1, promotes immune self-tolerance through T-cell inactivation and apoptosis [3,4,5].